PapersPMID:26640504
Probiotic strain Bacillus subtilis CU1 stimulates immune system of elderly during common infectious disease period: a randomized, double-blind placebo-controlled study.
- findings
- 3
- compound
- 1
- endpoints
- 3
- Study, every finding
- RCT · 10 days
- Dose studied, every finding
- one capsule daily (2 x 10^9 spores) 40 min before breakfast, in 10-day courses alternating with 18-day breaks; this measure across the first 10-day course
- Population, every finding
- Healthy free-living adults aged 60-74 reporting at least two common infectious disease episodes the previous winter; biological subset of the first 44 randomised (22 per arm), sampled before and after the first 10-day consumption course, winter 2010-2011
No finding here moved its endpoint.
What did not
How to read these marks →“No statistically significant differences in the plasma concentrations of cytokines (IL-1beta, IL-4, IL-6, IL-8, IL-10, IL-12p70, IgA, and TNF-alpha) were measured between the probiotic and the placebo groups from pre- to post- supplementation.”
- Interests
- Industry funded
- Interests
- Industry funded
- Interests
- Industry funded